Watertime, Author at PsyNews.com

Home Authors Posts by Watertime

368 POSTS 0 COMMENTS

Compass Pathways’ Psilocybin Clears First Phase 3 Hurdle

PS 25 Morning Show – Day Three

When it Comes to Psychedelic Access, It’s the Messenger, Not the...

Australia’s Largest Private Health Insurer Commits $10M to Fund MDMA Therapy...

Ibogaine and the Future of Healing: Trevor Millar & Jonathan Dickinson...

Accredited Entheogenic Seminary: Inside the Congregation for Sacred Practices with Paul...

Does Cannabis Research Deserve As Much Funding As Ibogaine Research?

May 2025 Psychedelic Patent Update: Gilgamesh Broadens Moat Around Lead Candidate...

1...151617...37 Page 16 of 37

The Psychedelic News Feed: January 05 – 11, 2026

From Brussels to the Ballot: How PsychedeliCare Took Psychedelic Therapy to...

Psychedelic Medicine at the Edge of Science and Spirit

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Watertime

Compass Pathways’ Psilocybin Clears First Phase 3 Hurdle

PS 25 Morning Show – Day Three

PS 25 Morning Show – Day Two

When it Comes to Psychedelic Access, It’s the Messenger, Not the...

PS 25 Morning Show – Day One